Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
511. |
ECCT/11/12/02 | VAC 46 Trial Efficacy Study of ChAd63-MVA ME-TRAP prime-boost Vaccination against Plasmodium falciparum infection. |
Principal Investigator(s) 1. Caroline Amolo Ogwang Site(s) in Kenya Junju Dispensary |
19-12-2013 |
View |
512. |
ECCT/08/20/01 | Partners PrEP Study Parallel comparison of Tenofovir and Emtricitabine/Tenofovir pre exposure prophylaxis to prevent HIV-1 acquisition within HIV-1 discordant couples |
Principal Investigator(s) 1. James Njogu Kiarie 2. CAREY FARQUHAR, 3. Grace John Stewart Site(s) in Kenya 1. Nairobi (Nairobi City county) 2. Thika (Kiambu county) 3. Eldoret (Uasin Gishu county) 4. Kisumu (Kisumu county) |
09-10-2013 |
View |
513. |
ECCT/13/10/02 | CEM ART Cohort Event Monitoring of Antiretroviral Medicines Use in Kenya |
Principal Investigator(s) 1. Caroline Olwande 2. Irene Mukui 3. Maureen Kimani 4. Edward Abwao 5. Ndinda Kusu 6. Maureen Kimani 7. Edward Abwao 8. Ndinda Kusu Site(s) in Kenya 1. Nyeri Provincial General Hospital (Nyeri county) 2. Thika Level 5 Hospital (Kiambu county) 3. Machakos Level 5 Hospital (Machakos county) 4. Vihiga District Hospital (Vihiga county) 5. Kisii Level 5 Hospital (Kisii county) 6. St Camillus Mission Hospital (Migori county) 7. Nakuru Provincial General Hospital (Nakuru county) 8. Coast Provincial General Hospital (Mombasa county) |
30-09-2013 |
View |
514. |
ECCT/13/10/01 | Clinical Trial of Acceptability, Adherence and Biologic Effects of a Vaginal Contraceptive Ring among Women in Western Kenya |
Principal Investigator(s) 1. Fredrick Odhiambo Otieno 2. Lisa Ann Mills Site(s) in Kenya KEMRI/CDC Research and Public Health Collaboration |
27-09-2013 |
View |
515. |
ECCT/10/09/03 | A0661201 A0661201 AN OPEN LABEL, NON-COMPARATIVE STUDY TO EVALUATE PARASITOLOGICAL CLEARANCE RATES AND PHARMACOKINETICS OF AZITHROMYCIN AND CHLOROQUINE FOLLOWING ADMINISTRATION OF A FIXED DOSE COMBINATION OF AZITHROMYCIN AND CHLOROQUINE (AZCQ) IN ASYMPTOMATIC PREGNANT WOMEN WITH PLASMODIUMFALCIPARUM PARASITEMIA IN SUB-SAHARAN AFRICA |
Principal Investigator(s) 1. Joshua Kimani Site(s) in Kenya University of Nairobi Institute of Tropical and Infectious Diseases Siaya District Hospital |
25-09-2013 |
View |
516. |
ECCT/13/08/01 | M72/AS01 E A phase IIb, double-blind, randomised, placebo-controlled study to evaluate the efficacy, safety and immunogenicity of GSK Biologicals’ candidatetuberculosis (TB) vaccine GSK 692342 against TB disease, in healthy adults aged 18-50 years, living in a TB endemic region. |
Principal Investigator(s) 1. Dr Videlis Nduba Site(s) in Kenya KEMRI-CDC |
06-08-2013 |
View |
517. |
ECCT/13/08/02 | MalPaC Trial Comparing drug-regimens for clearing parasites in Phase IIb trial designs prior to PCR monitoring for Plasmodium falciparum infection. |
Principal Investigator(s) 1. Caroline Amolo Ogwang 2. Francis Maina Ndung\'u Site(s) in Kenya Junju |
29-07-2013 |
View |
518. |
ECCT/09/03/01 | REMoxTB A randomised placebo – controlled double blind trial comparing two treatment shortening regimens with the standard regimen (two months ethambutol, isoniazid, rifampicin and pyrazinamide followed by four months isoniazid and rifampicin) namely 1) two months moxifloxacin, isoniazid, rifampicin and pyrazinamide followed by two months moxifloxacin, isoniazid and rifampicin and 2) two months ethambutol, moxifloxacin, rifampicin and pyrazinamide followed by two months moxifloxacin and rifampicin for the treatment of adults with pulmonary tuberculosis |
Principal Investigator(s) 1. Evans Inyangala Amukoye Site(s) in Kenya Kibera D.O Health Centre |
01-07-2013 |
View |
519. |
ECCT/13/07/05 | Single Dose Escalating, Single-blind Phase 1 Trial in Healthy Male Volunteers to Evalute the Safety, Tolerability and the Pharmacokinetics of Oleylphosphocholine. |
Principal Investigator(s) 1. Rashid Ravasco Juma Site(s) in Kenya KEMRI Centre for Clinical Research |
25-06-2013 |
View |
520. |
ECCT/13/07/01 | HIVCORE004/N004 A phase I/IIa clinical trial of universal HIV-1 vaccines pSG2.HIVconsv DNA, MVA.HIVconsv and ChAdV63.HIVconsv in combined regimens in healthy HIV-1/2-negative adults in Nairobi. |
Principal Investigator(s) 1. Prof. Walter Godfrey Jaoko Site(s) in Kenya KAVI-KANGEMI RESEARCH SITE |
19-06-2013 |
View |